Stenocare A/S (CPH:STENO)

Market Cap	27.65M -53.9%
Revenue (ttm)	12.54M +121.0%
Net Income	-1.74M
EPS	-0.04
Shares Out	43.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,485
Open	0.6100
Previous Close	0.7040
Day's Range	0.6100 - 0.6880
52-Week Range	0.5700 - 2.8000
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 4
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: STENO

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.56% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 6, 2026

Data Sources Report a data error